Sign Up to like & get
recommendations!
0
Published in 2020 at "Bioengineering"
DOI: 10.3390/bioengineering7020059
Abstract: High-dose recombinant interleukin 2 (IL2) therapy has been shown to be successful in renal cell carcinoma and metastatic melanoma. However, systemic administration of high doses of IL2 can be toxic, causing capillary leakage syndrome and…
read more here.
Keywords:
bfp;
hadscs il2;
proliferation;
hadscs ... See more keywords